Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer’s Disease and Parkinson’s Disease Dementia?

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works

Whole Brain Segmentation

Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610 · see citing works

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

Overdependence on degraded gist memory in Alzheimer's disease.

Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,756 · see citing works

Automatically Parcellating the Human Cerebral Cortex

Fischl, B. R. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg087 · Cited by 4,208 · see citing works

Microglia: Active sensor and versatile effector cells in the normal and pathologic brain

Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676 · see citing works

M-1/M-2 Macrophages and the Th1/Th2 Paradigm

Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287 · see citing works

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190 · see citing works

Neuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed

Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748 · see citing works

Inflammation in neurodegenerative diseases

Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355 · see citing works

Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention

Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095 · see citing works

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · see citing works

Does neuroinflammation fan the flame in neurodegenerative diseases?

Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751 · see citing works

Dementia associated with Parkinson's disease

Emre, M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00351-x · Cited by 686 · see citing works

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

Edison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513 · see citing works

Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches

Morales, I., Guzmán-Martínez, L., Cerda-Troncoso, C., Farías, G. A., & Maccioni, R. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00112 · Cited by 490 · see citing works

Microglial Phagocytosis Induced by Fibrillar β-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines

Koenigsknecht-Talboo, J., & Landreth, G. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1808-05.2005 · Cited by 477 · see citing works

Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia

Laakso, M. P., Partanen, K. P. L., Riekkinen, P., Lehtovirta, M., Helkala, E.-L., Hallikainen, M., Hänninen, T., Vainio, P. A., & Soininen, H. S. (1996) · Neurology · doi:10.1212/wnl.46.3.678 · Cited by 433 · see citing works

Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy

Chung, C. Y., Koprich, J. B., Siddiqi, H. K., & Ole Isacson, A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5427-08.2009 · Cited by 392 · see citing works

Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging

Lavisse, S., Guillermier, M., Hérard, A., Petit, F., Delahaye, M., Camp, N. V., Haim, L. B., Lebon, V., Rémy, P., Dollé, F., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1487-12.2012 · Cited by 362 · see citing works

In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease

Kreisl, W. C., Lyoo, C. H., McGwier, M., Snow, J., Jenko, K. J., Kimura, N., Corona, W., Morse, C. L., Zoghbi, S. S., Pike, V. W., et al. (2013) · Brain · doi:10.1093/brain/awt145 · Cited by 350 · see citing works

Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis

Doens, D., & Fernández, P. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-48 · Cited by 348 · see citing works

Parkinson's disease is associated with hippocampal atrophy

Camicioli, R. M., Moore, M. M., Kinney, A. E. “., Corbridge, E., Glassberg, K., & Kaye, J. A. (2003) · Movement Disorders · doi:10.1002/mds.10444 · Cited by 330 · see citing works

Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions

Laakso, M. P., Soininen, H. S., Partanen, K. P. L., Helkala, E.-L., Hartikainen, P. H., Vainio, P. A., Hallikainen, M., Hänninen, T., & Riekkinen, P. J. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252964 · Cited by 293 · see citing works

Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study

Gerhard, A., Schwarz, J., Myers, R., Wise, R. J. S., & Banati, R. B. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.09.034 · Cited by 286 · see citing works

Microglia, Amyloid, and Glucose Metabolism in Parkinson’s Disease with and without Dementia

Edison, P., Ahmed, I., Fan, Z., Hinz, R., Gelosa, G., Chaudhuri, К. R., Walker, Z., Turkheimer, F., & Brooks, D. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.255 · Cited by 275 · see citing works

Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker

Kreisl, W. C., Fujita, M., Fujimura, Y., Kimura, N., Jenko, K. J., Kannan, P., Hong, J. S., Morse, C. L., Zoghbi, S. S., Gladding, R. L., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.056 · Cited by 275 · see citing works

Reference and target region modeling of [11C]-(R)-PK11195 brain studies.

Turkheimer, F., Edison, P., Pavese, N., Roncaroli, F., Anderson, A. N., Hammers, A., Gerhard, A., Hinz, R., Tai, Y., & Brooks, D. J. (2007) · PubMed · Cited by 275 · see citing works

A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry

Beyer, M. K., Janvin, C. C., Larsen, J. O., & Aarsland, D. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.093849 · Cited by 255 · see citing works

Grey matter atrophy in cognitively impaired Parkinson's disease

Melzer, T. R., Watts, R., MacAskill, M. R., Pitcher, T. L., Livingston, L., Keenan, R. J., Dalrymple‐Alford, J. C., & Anderson, T. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300828 · Cited by 244 · see citing works

Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia

Fan, Z., Aman, Y., Ahmed, I., Chetelat, G., Landeau, B., Ray Chaudhuri, K., Brooks, D. J., & Edison, P. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.016 · Cited by 212 · see citing works

Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia

Apostolova, L. G., Beyer, M. K., Green, A. E., Hwang, K., Morra, J. H., Chou, Y., Avedissian, C., Aarsland, D., Janvin, C. C., Larsen, J. O., et al. (2010) · Movement Disorders · doi:10.1002/mds.22799 · Cited by 173 · see citing works

Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies

Ji, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M.-R., Suzuki, K., Ando, K., Staufenbiel, M., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2312-08.2008 · Cited by 169 · see citing works

Cerebral atrophy in mild cognitive impairment and Alzheimer disease

Leung, K. K., Bartlett, J. W., Barnes, J., Manning, E. N., Sebastien Ourselin, A., Fox, N. C., & Initiative, A. D. N. (2013) · Neurology · doi:10.1212/wnl.0b013e318281ccd3 · Cited by 165 · see citing works

Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process

Gonzalez-Redondo, R., García‐García, D., Clavero, P., Gasca‐Salas, C., de Eulate, M. R. G., Zubieta, J. L., Arbizu, J., Obeso, J. A., & Rodríguez‐Oroz, M. (2014) · Brain · doi:10.1093/brain/awu159 · Cited by 163 · see citing works

Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.

Borght, T. V., Minoshima, S., Giordani, B., Foster, N. L., Frey, K. A., Berent, S., Albin, R. L., Koeppe, R. A., & Kuhl, D. E. (1997) · PubMed · Cited by 160 · see citing works

Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer’s disease

Fan, Z., Okello, A. A., Brooks, D. J., & Edison, P. (2015) · Brain · doi:10.1093/brain/awv288 · Cited by 135 · see citing works

Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor

Maeda, J., Higuchi, M., Inaji, M., Ji, B., Haneda, E., Okauchi, T., Zhang, M., Suzuki, K., & Suhara, T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.054 · Cited by 134 · see citing works

Autonomic Dysfunction in Alzheimer's Disease: Tools for Assessment and Review of the Literature

Femminella, G. D., Rengo, G., Komici, K., Iacotucci, P., Petraglia, L., Pagano, G., de Lucia, C., Canonico, V., Bonaduce, D., Leosco, D., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140513 · Cited by 124 · see citing works

In vivo imaging of neuroinflammation

Cagnin, A. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00107-4 · Cited by 110 · see citing works

Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects

Jučaitė, A., Cselényi, Z., Arvidsson, A., Åhlberg, G., Julin, P., Varnäs, K., Stenkrona, P., Andersson, J. D., Halldin, C., & Farde, L. (2012) · EJNMMI Research · doi:10.1186/2191-219x-2-15 · Cited by 101 · see citing works

Dementia with Lewy Bodies versus Alzheimer's Disease and Parkinson's Disease Dementia: A Comparison of Cognitive Profiles

Park, K. W., Kim, H. S., Cheon, S., Cha, J., Kim, S., & Kim, J. W. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.1.19 · Cited by 84 · see citing works

Generative FDG-PET and MRI Model of Aging and Disease Progression in Alzheimer's Disease

Dukart, J., Kherif, F., Mueller, K., Adaszewski, S., Schroeter, M. L., Frackowiak, R. S. J., Draganski, B., & Initiative, A. D. N. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002987 · Cited by 80 · see citing works

Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP/PS1 transgenic mice

Jardanhazi‐Kurutz, D., Kummer, M. P., Terwel, D., Vogel, K., Thiele, A., & Heneka, M. T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.052 · Cited by 72 · see citing works

MRI Temporal Lobe Volume Measures and Neuropsychologic Function in Alzheimer's Disease

Smith, C. D., Malcein, M., Meurer, K., Schmitt, F. A., Markesbery, W. R., & Pettigrew, L. C. (1999) · Journal of Neuroimaging · doi:10.1111/jon1999912 · Cited by 61 · see citing works

Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease

Pradhan, S., & Andreasson, K. I. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.12.008 · Cited by 43 · see citing works

A systematic comparison of kinetic modelling methods generating parametric maps for [11C]-(R)-PK11195

Anderson, A. N., Pavese, N., Edison, P., Tai, Y., Hammers, A., Gerhard, A., Brooks, D. J., & Turkheimer, F. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.02.017 · Cited by 42 · see citing works

Cognitive Profiles of Patients with Mild Cognitive Impairment or Dementia in Alzheimer's or Parkinson's Disease

Hildebrandt, H., Fink, F., Kastrup, A., Haupts, M. R., & Eling, P. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000348350 · Cited by 37 · see citing works

β-Adrenergic Receptors and G Protein-Coupled Receptor Kinase-2 in Alzheimer's Disease: A New Paradigm for Prognosis and Therapy?

Femminella, G. D., Rengo, G., Pagano, G., de Lucia, C., Komici, K., Parisi, V., Cannavò, A., Liccardo, D., Vigorito, C., Filardi, P. P., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121813 · Cited by 32 · see citing works

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179 · see citing works

Alzheimer's disease

Lane, C. A., Hardy, J., & Schott, J. M. (2018) · European Journal of Neurology · doi:10.1111/ene.13439 · Cited by 2,616 · see citing works

Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation

Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750 · see citing works

Neuroinflammation in mild cognitive impairment and Alzheimer’s disease: A meta-analysis

Bradburn, S., Murgatroyd, C., & Ray, N. J. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.002 · Cited by 261 · see citing works

Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease

Malpetti, M., Kievit, R. A., Passamonti, L., Jones, P. S., Tsvetanov, K. A., Rittman, T., Mak, E., Nicastro, N., Bevan-Jones, W. R., Su, L., et al. (2020) · Brain · doi:10.1093/brain/awaa088 · Cited by 194 · see citing works

Microglial Activation Contributes to Cognitive Impairments in Rotenone-Induced Mouse Parkinson’s Disease Model

Zhang, D., Li, S., Hou, L., Jing, L., Ruan, Z., Peng, B., Zhang, X., Hong, J.-S., Zhao, J., & Wang, Q. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02065-z · Cited by 187 · see citing works

Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases

Dupont, A.-C., Largeau, B., Santiago Ribeiro, M., Guilloteau, D., Tronel, C., & Arlicot, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040785 · Cited by 182 · see citing works

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment

Chandra, A., Valkimadi, P., Pagano, G., Cousins, O., Dervenoulas, G., Politis, M., & Initiative, A. D. N. (2019) · Human Brain Mapping · doi:10.1002/hbm.24782 · Cited by 187 · see citing works

Pharmacological Targeting of Microglial Activation: New Therapeutic Approach

Liu, C.-Y., Wang, X., Liu, C., & Zhang, H.-L. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00514 · Cited by 133 · see citing works

Ferroptosis Mediated by Lipid Reactive Oxygen Species: A Possible Causal Link of Neuroinflammation to Neurological Disorders

Cheng, Y., Song, Y., Chen, H., Li, Q., Gao, Y. Z., Lu, G., & Luo, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5005136 · Cited by 122 · see citing works

Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume

Femminella, G. D., Dani, M., Wood, M., Fan, Z., Calsolaro, V., Atkinson, R., Edginton, T. L., Hinz, R., Brooks, D. J., & Edison, P. (2019) · Neurology · doi:10.1212/wnl.0000000000007133 · Cited by 109 · see citing works

Secretome from SH-SY5Y APPSwe cells trigger time-dependent CHME3 microglia activation phenotypes, ultimately leading to miR-21 exosome shuttling

Fernandes, A., Ribeiro, A. R., Monteiro, M., Garcia, G., Vaz, A. R., & Brites, D. (2018) · Biochimie · doi:10.1016/j.biochi.2018.05.015 · Cited by 93 · see citing works

Crosstalk between endoplasmic reticulum stress and brain inflammation in Alzheimer's disease

Santos, L. E., & Ferreira, S. T. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.016 · Cited by 92 · see citing works

In vivo Imaging of Glial Activation in Alzheimer's Disease

Edison, P., Donat, C. K., & Sastre, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00625 · Cited by 86 · see citing works

Biomarkers for Alzheimer’s Disease

Guzman-Martinez, L., Maccioni, R. B., Farías, G. A., Fuentes, P., & Navarrete, L. P. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190517121140 · Cited by 87 · see citing works

TSPO PET brain inflammation imaging: A transdiagnostic systematic review and meta-analysis of 156 case-control studies

Picker, L. D., Morrens, M., Branchi, I., Haarman, B. C. M., Terada, T., Kang, M. S., Boche, D., Tremblay, M., Leroy, C., Bottlaender, M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.023 · Cited by 78 · see citing works

Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging

Cerami, C., Iaccarino, L., & Perani, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050993 · Cited by 75 · see citing works

In vivo PET imaging of neuroinflammation in Alzheimer’s disease

Lagarde, J., Sarazin, M., & Bottlaender, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1731-x · Cited by 70 · see citing works

Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review

Femminella, G. D., Thayanandan, T., Calsolaro, V., Komici, K., Rengo, G., Corbi, G., & Ferrara, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123702 · Cited by 68 · see citing works

Neuroinflammatory Biomarkers in Alzheimer’s Disease: From Pathophysiology to Clinical Implications

Roveta, F., Bonino, L., Piella, E. M., Rainero, I., & Rubino, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211941 · Cited by 70 · see citing works

Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis

Wang, M., Tang, G., Zhou, C., Guo, H., Hu, Z., Hu, Q., & Li, G. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110387 · Cited by 62 · see citing works

Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease

Contador, J., Pérez‐Millan, A., Tort‐Merino, A., Balasa, M., Falgàs, N., Olives, J., Castellví, M., Borrego‐Écija, S., Bosch, B., Fernández‐Villullas, G., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102804 · Cited by 62 · see citing works

Neuroinflammation in Parkinson's disease: a meta-analysis of PET imaging studies

Zhang, P., & Gao, F. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10877-z · Cited by 58 · see citing works

Novel Microglia-based Therapeutic Approaches to Neurodegenerative Disorders

Zhang, L., Wang, Y., Liu, T., Mao, Y. Q., & Peng, B. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-01013-6 · Cited by 56 · see citing works

Brain-Derived Neurotrophic Factor: A Novel Dynamically Regulated Therapeutic Modulator in Neurological Disorders

Sharma, V., Singh, T. G., Kaur, A., Mannan, A., & Dhiman, S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03755-1 · Cited by 55 · see citing works

Taurine improves neuron injuries and cognitive impairment in a mouse Parkinson’s disease model through inhibition of microglial activation

Wang, K., Shi, Y., Liu, W., Liu, S., & Sun, M. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.01.002 · Cited by 50 · see citing works

Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders

Battaglini, M., Marino, A., Montorsi, M., Carmignani, A., Ceccarelli, M. C., & Ciofani, G. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202304180 · Cited by 52 · see citing works

Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice

Fertan, E., Stover, K. R., Brant, M. G., Stafford, P. M., Kelly, B., Diez‐Cecilia, E., Wong, A. A., Weaver, D. F., & Brown, R. E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01044 · Cited by 48 · see citing works

Brain Volume Changes in Patients with Acute Brain Dysfunction Due to Sepsis

Orhun, G., Tüzün, E., Bılgıç, B., Özcan, P. E., Sencer, S., Barbüroğlu, M., & Esen, F. (2019) · Neurocritical Care · doi:10.1007/s12028-019-00759-8 · Cited by 47 · see citing works

Dendrimers in Neurodegenerative Diseases

Pérez‐Carrión, M. D., & Posadas, I. (2023) · Processes · doi:10.3390/pr11020319 · Cited by 44 · see citing works

Biomarkers for Alzheimer's disease

Pauwels, E. K. J., Volterani, D., & Marlani, G. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.3.1354128 · Cited by 42 · see citing works

Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias

Bohnen, N. I., Müller, M. L. T. M., & Frey, K. A. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0789-z · Cited by 39 · see citing works

Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies

Fixemer, S., Ameli, C., Hammer, G. P., Salamanca, L., Huarte, O. U., Schwartz, C., Gérardy, J., Mechawar, N., Skupin, A., Mittelbronn, M. G. A., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01342-7 · Cited by 35 · see citing works

Bergenin Ameliorates MPTP-Induced Parkinson’s Disease by Activating PI3K/Akt Signaling Pathway

Ji, Y., Wang, D., Zhang, B., & Lu, H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190870 · Cited by 34 · see citing works

Neuroimaging of mouse models of Alzheimer’s disease

Jullienne, A., Trinh, M. V., & Obenaus, A. (2022) · Biomedicines · doi:10.3390/biomedicines10020305 · Cited by 32 · see citing works

Relationship between tau, neuroinflammation and atrophy in Alzheimer's disease: The NIMROD study

Su, L., Surendranathan, A., Huang, Y., Bevan-Jones, W. R., Passamonti, L., Hong, Y. T., Arnold, R. J., Rodríguez, P. V., Wang, Y., Mak, E., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.10.006 · Cited by 30 · see citing works

APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly

Snellman, A., Ekblad, L. L., Tuisku, J., Koivumäki, M., Ashton, N. J., Lantero‐Rodriguez, J., Karikari, T. K., Helin, S., Bucci, M., Löyttyniemi, E., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01209-6 · Cited by 30 · see citing works

Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer's Disease Continuum

Bieger, A., Rocha, A., Bellaver, B., Machado, L. S., Ros, L. U. D., Borelli, W. V., Therriault, J., Macedo, A. C., Pascoal, T. A., Gauthier, S. G., et al. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.54 · Cited by 29 · see citing works

Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase–NLRP3 inflammasome axis-dependent microglial activation

Hou, L., Liu, J., Sun, F., Huang, R., Chang, R., Ruan, Z., Wang, Y., Zhao, J., & Wang, Q. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02732-x · Cited by 30 · see citing works

Gray matter changes related to microglial activation in Alzheimer's disease

Nicastro, N., Malpetti, M., Mak, E., Williams, G. B., Bevan-Jones, W. R., Carter, S. F., Passamonti, L., Fryer, T., Hong, Y. T., Aigbirhio, F., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.010 · Cited by 25 · see citing works

Common and Rare Variants in TMEM175 Gene Concur to the Pathogenesis of Parkinson’s Disease in Italian Patients

Palomba, N. P., Fortunato, G., Pepe, G., Modugno, N., Pietracupa, S., Damiano, I., Mascio, G., Carrillo, F., Giovannantonio, L. G. D., Ianiro, L., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03203-9 · Cited by 26 · see citing works

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials

Siderowf, A. D., Aarsland, D., Mollenhauer, B., Goldman, J. G., & Ravina, B. M. (2018) · Movement Disorders · doi:10.1002/mds.27355 · Cited by 25 · see citing works

Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review

Loveland, P. M., Yu, J. J., Churilov, L. P., Yassi, N., & Watson, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512116 · Cited by 21 · see citing works

Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease

Roussakis, A., & Piccini, P. P. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.08.009 · Cited by 21 · see citing works

Early Approaches of YKL-40 As a Biomarker and Therapeutic Target for Parkinson’s Disease

Anwar, M. M., & Fathi, M. H. (2023) · Neurodegenerative Disease Management · doi:10.2217/nmt-2022-0010 · Cited by 19 · see citing works

Microglia Biomarkers in Alzheimer’s Disease

Zhang, P., Hu, H., Tan, L., & Yu, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02348-3 · Cited by 18 · see citing works

Dual PET-fMRI reveals a link between neuroinflammation, amyloid binding and compensatory task-related brain activity in Alzheimer’s disease

Canário, N., Jorge, L., Martins, R., Santana, I. J., & Castelo-Branco, M. S. (2022) · Communications Biology · doi:10.1038/s42003-022-03761-7 · Cited by 17 · see citing works

Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease

Martín‐Bastida, A., Delgado‐Alvarado, M., Navalpotro‐Gómez, I., & Rodríguez‐Oroz, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.733570 · Cited by 13 · see citing works

Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro

Dragović, I. R., Popović, N., Ždralević, M., Radulović, L., Vuković, T., Marzano, F., Tullo, A., & Radunović, M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220676 · Cited by 14 · see citing works

Memory impairment induced by aluminum nanoparticles is associated with hippocampal IL-1 and IBA-1 upregulation in mice

Izadi, S., Abdolrezaei, M., SoukhakLari, R., & Moosavi, M. (2023) · Neurological Research · doi:10.1080/01616412.2023.2298137 · Cited by 12 · see citing works

Stress Response and Hearing Loss Differentially Contribute to Dynamic Alterations in Hippocampal Neurogenesis and Microglial Reactivity in Mice Exposed to Acute Noise Exposure

Li, Q., Li, H., Yao, X., Wang, C., Liu, H., Xu, D., Yang, C., Zhuang, H., Xiao, Y. M., Liu, R., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.749925 · Cited by 13 · see citing works

Probable Reasons for Neuron Copper Deficiency in the Brain of Patients with Alzheimer’s Disease: The Complex Role of Amyloid

Bagheri, S., Saboury, A. A., Haertlé, T., Rongioletti, M. C. A., & Saso, L. (2022) · Inorganics · doi:10.3390/inorganics10010006 · Cited by 13 · see citing works

Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies

Perani, D., Iaccarino, L., Jacobs, A. H., IMBI Brain Imaging Working Group, Lammertsma, A. A., Nordberg, A. K., Windhorst, A. D., Gerhard, A., Winkeler, A., Jacobs, A. H., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.02.004 · Cited by 11 · see citing works

Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer’s Disease

Leng, F., Initiative, O. B. O. A. D. N., Zhan, Z., Sun, Y., Liu, F., Edison, P., Sun, Y., & Wang, Z. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220102 · Cited by 11 · see citing works

Neurodegeneration and the immune system: lessons from autoimmune encephalitis

Campetella, L., Smolik, K., Farina, A., Joubert, B., Muñiz‐Castrillo, S., Desestret, V., & Honnorat, J. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13094-0 · Cited by 10 · see citing works

The Adult Neurogenesis Theory of Alzheimer’s Disease

Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 8 · see citing works

The activation of SIRT1-Nrf2 axis exerts beneficial effects against rotenone-induced cognitive deficits in mice through inhibition of neuroinflammation and ferroptosis

Ma, Y., Zhang, J., Zhou, Q., Tang, P., Wang, X., Zhu, H., Huang, Z., Su, H., Zhai, X., & Wang, Q. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.119697 · Cited by 7 · see citing works

Novel brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer’s disease and mild cognitive impairment

Huang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010946 · Cited by 7 · see citing works

Diurnal cortisol, neuroinflammation, and neuroimaging visual rating scales in memory clinic patients

Holleman, J., Daniilidou, M., Kåreholt, I., Aspö, M., Hagman, G., Udeh‐Momoh, C. T., Spulber, G., Kivipelto, M., Solomon, A., Matton, A., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.024 · Cited by 6 · see citing works

Albiflorin ameliorates neuroinflammation and exerts neuroprotective effects in Parkinson’s disease models

Gao, Y., Chen, Y., Wang, N., & Meng, Q. (2025) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2025.2457960 · Cited by 6 · see citing works

TREM2 deficiency aggravates neuroinflammatory response and cognitive impairment via disease-associated microglia in Parkinson's disease models

Zhang, P., Baoyu, Z., Feng, J., Liang, X., Peiting, H., He, C., Deng, Y., Jia-hong, L., Lijuan, W., & Zhang, Y. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106068 · Cited by 6 · see citing works

Distinct inflammatory profiles in young‐onset versus late‐onset Alzheimer's disease

Thapa, S., Anastassiadis, C., Vasilevskaya, A., Taghdiri, F., Jurišica, I., Hadian, M., Salwierz, P., Robbani, F., Kivisäkk, P., Hyman, B. T., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70509 · Cited by 5 · see citing works

Filgrastim (G-CSF) ameliorates Parkinsonism l -dopa therapy’s drawbacks in mice

El‐Esawy, R. O., Balaha, M. F. H., Kandeel, S., Hadya, S., & Rahman, M.-N. A.-E. (2018) · Basal Ganglia · doi:10.1016/j.baga.2018.06.001 · Cited by 6 · see citing works

Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic review

Machado, L. S., Vidor, P. R., Perquim, L., Limberger, C., Machado, L., da Rocha, A. S., Soares, C., Rahmouni, N., Brum, W. S., Bellaver, B., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03160-4 · Cited by 5 · see citing works

Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects

Leng, F., Hinz, R., Gentleman, S., Dani, M., Brooks, D. J., & Edison, P. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230442 · Cited by 5 · see citing works

Exploring the molecular basis of the genetic correlation between body mass index and brain morphological traits

Fusco, D., Marinelli, C., André, M., Troiani, L., Noè, M., Pizzagalli, F., Marnetto, D., & Provero, P. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011658 · Cited by 3 · see citing works

α7 nicotinic acetylcholine receptor, activated glia, and cognitive impairment in schizophrenia: a dual-tracer PET study

Wakuda, T., Yokokura, M., Magata, Y., Suzuki, C., Murayama, C., Goto, T., Tamayama, T., Kameno, Y., Iwabuchi, T., Isobe, T., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03162-2 · Cited by 3 · see citing works

Parkinsonian Dementias: PET Findings

Kanel, P., Müller, M. L. T. M., & Bohnen, N. I. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_16 · Cited by 3 · see citing works

Heterogeneity of cerebral atrophic rate in mild cognitive impairment and its interactive association with proteins related to microglia activity on longitudinal cognitive changes

Tang, J., Cao, Z., Lei, M., Yu, Q., Mai, Y., Xu, J., Liao, W., Ruan, Y., Shi, L., Yang, L., et al. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105582 · Cited by 2 · see citing works

Textural properties of microglial activation in Alzheimer’s disease as measured by (R)-[11C]PK11195 PET

Pais, M. L., Jorge, L., Martins, R., Canário, N., Xavier, A. C., Bernardes, R., Abrunhosa, A., Santana, I. J., & Castelo-Branco, M. S. (2023) · Brain Communications · doi:10.1093/braincomms/fcad148 · Cited by 1 · see citing works

Parkinson’s Disease

Matarazzo, M., Felicio, A. C., & Stoessl, A. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_24 · Cited by 1 · see citing works

How molecular imaging studies can disentangle disease mechanisms in age-related neurodegenerative disorders

de Natale, E. R., Wilson, H., Udeh‐Momoh, C. T., Ford, J. K., Politis, M., & Middleton, L. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00022-7 · Cited by 1 · see citing works

Neural Substrates of Parkinson's Disease

Koshimori, Y. (2016) · TSpace (University of Toronto)

Pleiotropic Theory

Friel, H., & Frautschy, S. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812259-4.00006-0

Role of Inflammation in Lewy Body Dementia

Surendranathan, A., & O'Brien, J. T. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108539623.011

APOE ε4 gene dose effect on imaging and blood biomarkers of glial reactivity and β-amyloid pathologyPreprint

Snellman, A., Ekblad, L. L., Tuisku, J., Koivumäki, M., Ashton, N. J., Lantero‐Rodriguez, J., Karikari, T. K., Helin, S., Bucci, M., Löyttyniemi, E., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.19.508484

Additional file 3 of Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies

Fixemer, S., Ameli, C., Hammer, G. P., Salamanca, L., Huarte, O. U., Schwartz, C., Gérardy, J.-J., Mechawar, N., Skupin, A., Mittelbronn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19373331

Additional file 1 of Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase–NLRP3 inflammasome axis-dependent microglial activation

Hou, L., Liu, J., Sun, F., Huang, R., Chang, R., Ruan, Z., Wang, Y., Zhao, J., & Wang, Q. (2023) · Figshare · doi:10.6084/m9.figshare.22603573

Additional file 7 of Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies

Fixemer, S., Ameli, C., Hammer, G. P., Salamanca, L., Huarte, O. U., Schwartz, C., Gérardy, J.-J., Mechawar, N., Skupin, A., Mittelbronn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19373346

Additional file 1 of Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model

Zhang, D., Li, S., Hou, L., Lu, J., Ruan, Z., Peng, B., Zhang, X., Hong, J.-S., Zhao, J., & Wang, Q. (2021) · Figshare · doi:10.6084/m9.figshare.13525190

Additional file 2 of Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies

Fixemer, S., Ameli, C., Hammer, G. P., Salamanca, L., Huarte, O. U., Schwartz, C., Gérardy, J.-J., Mechawar, N., Skupin, A., Mittelbronn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19373328

Additional file 8 of Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies

Fixemer, S., Ameli, C., Hammer, G. P., Salamanca, L., Huarte, O. U., Schwartz, C., Gérardy, J.-J., Mechawar, N., Skupin, A., Mittelbronn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19373352

Additional file 6 of Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies

Fixemer, S., Ameli, C., Hammer, G. P., Salamanca, L., Huarte, O. U., Schwartz, C., Gérardy, J.-J., Mechawar, N., Skupin, A., Mittelbronn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19373343

Additional file 4 of Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies

Fixemer, S., Ameli, C., Hammer, G. P., Salamanca, L., Huarte, O. U., Schwartz, C., Gérardy, J.-J., Mechawar, N., Skupin, A., Mittelbronn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19373334

Additional file 1 of Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies

Fixemer, S., Ameli, C., Hammer, G. P., Salamanca, L., Huarte, O. U., Schwartz, C., Gérardy, J.-J., Mechawar, N., Skupin, A., Mittelbronn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19373325

Additional file 5 of Microglia phenotypes are associated with subregional patterns of concomitant tau, amyloid-β and α-synuclein pathologies in the hippocampus of patients with Alzheimer’s disease and dementia with Lewy bodies

Fixemer, S., Ameli, C., Hammer, G. P., Salamanca, L., Huarte, O. U., Schwartz, C., Gérardy, J.-J., Mechawar, N., Skupin, A., Mittelbronn, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19373337

Additional file 1 of APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly

Snellman, A., Ekblad, L. L., Tuisku, J., Koivumäki, M., Ashton, N. J., Lantero‐Rodriguez, J., Karikari, T. K., Helin, S., Bucci, M., Löyttyniemi, E., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22620676

Glaucoma and Systemic Neurodegeneration: Clinical Implications of the Brain–Eye Continuum—A Narrative Review

Ha, A. (2026) · Advances in Glaucoma · doi:10.36299/jkgs.2026.15.1.1

P4‐123: INFLUENCE OF MICROGLIAL ACTIVATION ON HIPPOCAMPAL ATROPHY IN ALZHEIMER'S AND PARKINSON's DISEASE DEMENTIA

Femminella, G. D., Ninan, S., Varley, J. A., Atkinson, R., Fan, Z., Brooks, D. J., & Edison, P. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.1639

O1‐02‐04: Glial activation influence on hippocampal volume and glucose metabolism in Alzheimer's disease and pdd

Femminella, G. D., Fan, Z., Atkinson, R., Brooks, D. J., & Edison, P. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.07.036

Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia

Fan, Z., Aman, Y., Ahmed, I., Chetelat, G., Landeau, B., Ray Chaudhuri, K., Brooks, D. J., & Edison, P. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.016 · Cited by 212 · see citing works

Influence of Neuroinflammation on Neuronal Function in Neurodegenerative Diseases: An 11C-(R)-PK11195 and 18F-FDG PET Study (S44.003)

Edison, P., Fan, Z., Aman, Y., & Brooks, D. J. (2013) · Neurology · doi:10.1212/wnl.80.7_supplement.s44.003

Influence of Neuroinflammation on Neuronal Function in Neurodegenerative Diseases: An 11C-(R)-PK11195 and 18F-FDG PET Study (IN9-1.001)

Edison, P., Fan, Z., Aman, Y., & Brooks, D. J. (2013) · Neurology · doi:10.1212/wnl.80.7_supplement.in9-1.001